Dashboard
Manage Tickers

ANVSAnnovis Bio, Inc.

NYSE annovisbio.com


$ 5.56 $ -0.53 (-8.7 %)    

Tuesday, 25-Jun-2024 15:56:38 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 5.56
$ 5.72
$ 0.00 x 0
$ 0.00 x 0
$ 5.56 - $ 5.93
$ 4.79 - $ 22.49
208,028
na
60.19M
$ 1.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-02-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 03-03-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 03-25-2020 12-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

annovis-bio-selected-to-present-latest-alzheimers-study-data-at-alzheimers-association-international-conference-2024-in-philadelphia
Annovis Bio Selected to Present Latest Alz...
06/18/2024 12:14:59

hc-wainwright--co-reiterates-buy-on-annovis-bio-maintains-23-price-target
HC Wainwright & Co. Reiterates Buy on Anno...
06/12/2024 10:46:41

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Annovis Bio (NYSE:ANVS) with a Buy and maintains $23 price tar...

annovis-bios-recent-phase-iiiii-alzheimers-study-of-buntanetap-showed-statistically-significant-efficacy-and-safety-in-both-carriers-and-non-carriers-of-apolipoprotein-e4-a-genetic-cause-of-ad
Annovis Bio's Recent Phase II/III Alzheime...
06/11/2024 12:08:23

Annovis Bio Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage drug platform company developing novel ...

rodman--renshaw-initiates-coverage-on-annovis-bio-with-buy-rating-announces-price-target-of-67
Rodman & Renshaw Initiates Coverage On Ann...
06/04/2024 16:51:30

Rodman & Renshaw initiates coverage on Annovis Bio (NYSE:ANVS) with a Buy rating and announces Price Target of $67.

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
05/31/2024 16:31:09

peering-into-annovis-bios-recent-short-interest
Peering Into Annovis Bio's Recent Short In...
05/29/2024 16:00:16

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/14/2024 17:35:24

hc-wainwright--co-maintains-buy-on-annovis-bio-lowers-price-target-to-23
HC Wainwright & Co. Maintains Buy on Annov...
05/13/2024 11:49:58

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target ...

annovis-bios-cash-and-cash-equivalents-totaled-31m-as-of-march-31-2024-will-fund-its-operations-into-the-fourth-quarter-of-2024
Annovis Bio's Cash And Cash Equivalents To...
05/13/2024 11:42:15

annovis-bio-q1-2024-gaap-eps-072-beats-086-estimate
Annovis Bio Q1 2024 GAAP EPS $(0.72) Beats...
05/13/2024 11:40:57

annovis-reports-completion-of-data-cleaning-for-phase-iii-study-of-buntanetap-in-patients-with-early-parkinsons-disease-topline-efficacy-data-is-expected-in-june
Annovis Reports Completion Of Data Cleanin...
05/09/2024 11:54:25

annovis-bio-ceo-outlines-next-steps-in-alzheimers-research-after-mixed-phase-iiiii-trial-results
Annovis Bio CEO Outlines Next Steps in Alz...
05/06/2024 11:35:40

Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company developing n...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 16:31:18

canaccord-genuity-maintains-buy-on-annovis-bio-lowers-price-target-to-26
Canaccord Genuity Maintains Buy on Annovis...
04/30/2024 12:02:53

Canaccord Genuity analyst Sumant Kulkarni maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $36 ...

hc-wainwright--co-reiterates-buy-on-annovis-bio-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Anno...
04/30/2024 10:25:09

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Annovis Bio (NYSE:ANVS) with a Buy and maintains $30 price tar...

sp-500-edges-higher-on-semiconductor-earnings-top-views
S&P 500 Edges Higher; ON Semiconductor Ear...
04/29/2024 18:34:41

why-is-alzheimers-focused-annovis-bio-stock-nosediving-on-monday
Why Is Alzheimer's-Focused Annovis Bio Sto...
04/29/2024 17:53:27

Annovis Bio faces setbacks in Phase 2/3 Alzheimer's study, revealing minimal change in patients' conditions. Despite sl...

Core News & Articles
Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/29/2024 16:31:20

annovis-bio-shares-halted-on-circuit-breaker-to-the-downside-stock-now-down--653
Annovis Bio Shares Halted On Circuit Break...
04/29/2024 15:53:10

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION